Toxic epidermal necrolysis after sun-exposure probably due to lamotrigine and chlorpromazine

Asian Journal of Psychiatry

Volumn 3, Issue 4, 2010, Pages 240-242

  Huang, Hsien Te ^a   Chang, Chen Lin ^a,b   Tzeng, Dong Sheng ^a,b,c  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Chlorpromazine; Lamotrigine; Sun exposure; Toxic epidermal necrolysis

Indexed keywords

ALPRAZOLAM; CARBAMAZEPINE; CEFAZOLIN; CHLORPROMAZINE; LAMOTRIGINE; LITHIUM; SULPIRIDE; ZOLPIDEM;

ADULT; AGITATION; ANTIBIOTIC THERAPY; BIPOLAR I DISORDER; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CONJUNCTIVITIS; CONSERVATIVE TREATMENT; DEHYDRATION; DESQUAMATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EVENING DOSAGE; FEVER; GRANDIOSE DELUSION; HOSPITALIZATION; HUMAN; HYDRATION; HYPERACTIVITY; INFECTION RISK; IRRITABILITY; LETTER; LEUKOCYTE COUNT; MALE; MOOD CHANGE; PRIORITY JOURNAL; PRURITUS; RASH; RESTLESSNESS; SLEEP DISORDER; STAB WOUND; SUN EXPOSURE; TOXIC EPIDERMAL NECROLYSIS;

EID: 78649895463     PISSN: 18762018     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajp.2010.09.002     Document Type: Letter

References (17)

1. Bastuji-Garin S., Rzany B., Stern R.S., et al. Clinical classification of cases of toxic epidermal necrolysis. Stevens-Johnson syndrome, and erythma multiforme. Arch. Dermatol. 1993, 129(1):92-96.
2. Betts T., Goodwin G., Withers R.M., et al. Human safety of lamotrigine. Epilepsia 1991, 32(Suppl. 2):517-521.
3. Bozikas V., Vartzopoulos D., Phocas C., et al. Lamotrigine-induced rash after sun exposure. Am. J. Psychiatry. 1999, 156:2015-2016.
4. Calabrese J.R., Bowden C.L., McElroy S.L., et al. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am. J. Psychiatry. 1999, 156:1019-1023.
5. Harth Y., Rapoport M. Photosensitivity associated with antipsychotics, antidepressants and anxiolytics. Drug Saf. 1996, 14:252-259.
6. Hirsch L.J., Weintraub D.B., Buchsbaum R., et al. Predictors of lamotrigine-associated rash. Epilepsia 2006, 47:318-322.
7. Kanner A.M. Lamotrigine-induced rash: can we stop worrying?. Epilepsy Curr. 2005, 5:190-191.
8. Léauté-Labrèze C., Lamireau T., Chawki D., et al. Diagnosis, classification, and management of erythma multiforme and Stevens-Johnson syndrome. Arch. Dis. Child. 2000, 83:347-352.
9. Li L.M., Russo M., O'Donoghur M.F., Duncan J.S., et al. Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk. Arq. Neuropsiquiatr. 1996, 54:47-49.
10. Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br. J. Dermatol. 1979, 100:69-86.
11. Moore D.E. Drug-induced cutaneous photosensitivity: incidence, mechanism. Prev. Manage. 2002, 25:345-372.
12. Purcell P., Valmana A. Toxic epidermal necrolysis following chlorpromazine ingestion complicated by SIADH. Postgrad. Med. J. 1996, 72:186.
13. Roujeau J.C., Kelly J.P., Naldi L., et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N. Eng. J. Med. 1995, 333:1600-1607.
14. Rzany B., Correia O., Kelly J.P., et al. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study group of the international case control study on severe cutaneous adverse reactions. Lancet 1999, 353:2190-2194.
15. Sporn J., Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J. Clin. Psychopharm. 1997, 17:185-189.
16. Teo L., Tay Y.K., Liu T.T., et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options. Singapore Med. J. 2009, 50:29-33.
17. Varghses S.P., Haith L.R., Patton M.L., et al. Lamotrigine-induced toxic epidermal necrolysis in three patients treated for bipolar disorder. Pharmacotherapy 2006, 26:699-704.